97 related articles for article (PubMed ID: 6989375)
1. Study of the chronic toxicity of D 53 by aerosol. One-year observation.
Fontanges R; Robert D; Isoard P
Arzneimittelforschung; 1980; 30(1a):187-96. PubMed ID: 6989375
[No Abstract] [Full Text] [Related]
2. Bacterial lysates and ribosomes as inducers of specific immune responses: a comparative study.
Béné MC; Kahl L; Perruchet AM; Hermes H; Mösges M; Normier G; Binz H; Faure GC
Scand J Immunol; 1993 Nov; 38(5):496-8. PubMed ID: 8235452
[TBL] [Abstract][Full Text] [Related]
3. Multicentric study of the effectiveness of ribosomal vaccine (D 53) in the prevention of episodes of bacterial infection encountered in ENT pathology.
Charachon R; Lavillauroy PJ; Fumex JP
Arzneimittelforschung; 1980; 30(1a):214-20. PubMed ID: 6892781
[No Abstract] [Full Text] [Related]
4. [Preventive immunoprevention of rhinitis and sinusitis. ENT director Dr. W. Elies, Bielefeld, elaborates on the indications].
Elies W
Fortschr Med; 1989 Sep; 107(26):70-1. PubMed ID: 2478431
[No Abstract] [Full Text] [Related]
5. Study of the teratogenic activity of ribosomal vaccine.
Labie C
Arzneimittelforschung; 1980; 30(1a):173-81. PubMed ID: 7370080
[TBL] [Abstract][Full Text] [Related]
6. Role of interferon in mice in protection against influenza A virus by bacterial ribosomes together with membranal glycoproteins of Klebsiella pneumoniae as adjuvant.
Robert D; Quillon JP; Ivanoff B; Beaudry Y; Fontanges R; Normier G; Pinel AM; D'hinterland LD
Infect Immun; 1979 Nov; 26(2):515-9. PubMed ID: 94908
[TBL] [Abstract][Full Text] [Related]
7. [Interferon in the anti-influenza protection provided by a mixtures of bacterial ribosomes and a membrane fraction of K. pneumoniae applied as an aerosol].
Fontanges R
Z Erkr Atmungsorgane; 1979 May; 153(2):241-9. PubMed ID: 94959
[No Abstract] [Full Text] [Related]
8. Immuno-stimulation by a ribosomal vaccine associated with a bacterial cell wall adjuvant in humans.
Michel FB; Dussourd D'Hinterland L; Bousquet J; Pinel AM; Normier G
Infect Immun; 1978 Jun; 20(3):760-9. PubMed ID: 27461
[TBL] [Abstract][Full Text] [Related]
9. Prevention of bacterial respiratory infection by a new vaccine, an association of bacterial ribosomes and membranous adjuvants. 1. General remarks.
Michel FB; Dussourd d'Hinterland L
Arzneimittelforschung; 1980; 30(1a):196-8. PubMed ID: 6892779
[No Abstract] [Full Text] [Related]
10. Immunostimulative action of Streptococcus pneumoniae and Klebsiella pneumoniae subcellular fractions. I. Determination of "in vivo" toxicity and of some non-specific immunostimulative properties.
Hoişie S; Pencea I; Popescu C; Grigoraş E; Lupuşoru C; Leibovici M; Buzdugan R; Anton D; Uliciuc S; Anicăi O
Arch Roum Pathol Exp Microbiol; 1985; 44(4):311-21. PubMed ID: 3915859
[No Abstract] [Full Text] [Related]
11. Bacterial crude extracts or ribosomes are recognized similarly by peripheral and mucosal B cells.
Zanin C; Béné MC; Perruchet AM; Perrin P; Martin F; Borelly J; Faure GC
FEMS Immunol Med Microbiol; 1994 Nov; 10(1):11-8. PubMed ID: 7874074
[TBL] [Abstract][Full Text] [Related]
12. Prevention of bacterial respiratory infection by an association of bacterial ribosomes and membranous proteoglycans. 2. Objective assessment of the response and of the immunological stimulation.
Michel FB; Dussourd d'Hinterland L; Pinel AM; Guendon R; Guerrero AJ; Moutou M; Bansard JP
Arzneimittelforschung; 1980; 30(1a):198-206. PubMed ID: 6892780
[TBL] [Abstract][Full Text] [Related]
13. Chemoprophylaxis in asplenic adolescents and young adults.
Buchanan GR
Pediatr Infect Dis J; 1993 Oct; 12(10):892-3. PubMed ID: 8284135
[No Abstract] [Full Text] [Related]
14. Immunomodulation of polymorphonuclear leukocytes by D53 Immucytal and its constitutive fractions.
Minonzio F; Ongari AM; Venegoni E; Carbonelli V; Licciardello L; Capsoni F
Boll Ist Sieroter Milan; 1989; 68(3):241-8. PubMed ID: 2491432
[TBL] [Abstract][Full Text] [Related]
15. [Studies in the BALB/c mouse of the efficiency of spraying as compared to other inoculation ways for immunostimulant (author's transl)].
Fontanges R; Cordel J; Ivanoff B; Robert D; Isoard P
Poumon Coeur; 1979; 35(6):383-90. PubMed ID: 400026
[TBL] [Abstract][Full Text] [Related]
16. Ribosomal vaccine chronic toxicity in the rat.
Lauressergues H; Rico A; Labie C
Arzneimittelforschung; 1980; 30(1a):182-6. PubMed ID: 7370081
[No Abstract] [Full Text] [Related]
17. Study of the immunogenicity of ribosomes and ribosomal RNA extracted from K. pneumoniae and S. pneumoniae.
Fontanges R; Robert D; Content Y; Nis G
Arzneimittelforschung; 1980; 30(1a):142-72. PubMed ID: 6154468
[No Abstract] [Full Text] [Related]
18. Use of new bacterial vaccines in children.
Klein JO
Isr J Med Sci; 1983 Nov; 19(11):1026-9. PubMed ID: 6420367
[No Abstract] [Full Text] [Related]
19. Otitis media: prospects for prevention.
Haggard M
Vaccine; 2008 Dec; 26 Suppl 7():G20-4. PubMed ID: 19094934
[TBL] [Abstract][Full Text] [Related]
20. Study of the mode of action of ribosomal vaccines from Klebsiella and Streptococcus pneumoniae and their ribonucleic and protein fractions using passive immunization.
Robert D; Ivanoff B; Fontanges R; Normier G; Pinel AM; Dussourd D'Hinterland L
Microbiol Immunol; 1982; 26(10):933-40. PubMed ID: 6186896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
